SmophyAI

Published daily · Next update 02:00 UTC

NVIDIA

NVIDIA: Nemotron 3 Ultra (free)

NVIDIA: Nemotron 3 Ultra (free) ranks #37 of 85 models by Artificial Analysis quality score (38.3) at $1.35/1M tokens blended - and ranks #7 of 291 by average real OpenRouter usage share over the trailing 35-day window (4.14%). Available from 4 providers at up to 99.7% uptime.

  1. Quality (Intelligence Index) - 38.3
  2. Coding index - 49.3
  3. Agentic index - 27.5
  4. Price (blended $/1M) - 1.35
  5. Context window - 512,288
  6. Usage rank - #7 of 291
  7. Providers - 4
  8. Open/closed - open

Usage share over time

7.73%5.79%3.86%1.93%0.00%Share of usageJul 5Jul 22Aug 8

What NVIDIA: Nemotron 3 Ultra (free) is actually used for

Share of each real task category's classified traffic this model handles, from OpenRouter's task classification.

TaskShare of task traffic
DevOps6.8%
DevOps & Config5.1%
Repo Scanning3.1%
Debugging3.0%
File I/O3.0%
Frontend & UI2.8%
Memory Extraction2.6%
Workflow Execution2.3%

Compare NVIDIA: Nemotron 3 Ultra (free)

Frequently asked questions

What is NVIDIA: Nemotron 3 Ultra (free)'s quality score?

NVIDIA: Nemotron 3 Ultra (free) scores 38.3 on Artificial Analysis's Intelligence Index, ranking #37 of 85 models with a published score.

How much does NVIDIA: Nemotron 3 Ultra (free) cost?

NVIDIA: Nemotron 3 Ultra (free) costs $1.35 per 1M tokens (blended 75% prompt / 25% completion pricing).

Is NVIDIA: Nemotron 3 Ultra (free) widely used?

NVIDIA: Nemotron 3 Ultra (free) ranks #7 of 291 models by average real OpenRouter usage share, averaging 4.14% of classified token volume over the trailing 35-day window.

Is NVIDIA: Nemotron 3 Ultra (free) open-weight or closed?

NVIDIA: Nemotron 3 Ultra (free) is an open-weight model.

Source: OpenRouter (openrouter.ai/rankings), as of August 9, 2026.

Benchmark scores: Artificial Analysis (artificialanalysis.ai) via OpenRouter (openrouter.ai/rankings).

Methodology: smophy.ai/benchmark/methodology

Token counts originate from each provider's own tokenizer and are not directly comparable across providers.